The Bruker Energy & Supercon Technologies (BEST) division, a Bruker subsidiary, has confirmed two multi-year MRI superconductor supply agreements with global healthcare companies, totalling approximately $500m in anticipated revenues.
The agreements expand previous frameworks, with one commitment extending up to seven years, and will see Bruker’s superconductors supplied primarily to magnetic resonance imaging (MRI) magnet manufacturing sites in the UK and the US.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Under the expanded arrangements, BEST will deliver high-performance superconductors engineered to meet advanced MRI magnet requirements for quality and performance.
Deliveries will be supported from Bruker’s manufacturing locations in the US and Europe, utilising its established supply chain. The agreements are intended to address evolving needs in radiology equipment, including support for new helium-free MRI magnet architectures that require stringent field stability and homogeneity.
Bruker’s expertise spans a range of high-temperature superconducting (HTS) and low-temperature superconducting (LTS) materials.
The technologies serve a broad spectrum of global markets, encompassing nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectroscopy, and other deep technology superconductivity applications.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBruker’s scientific instruments and analytical solutions are used by scientists and engineers for discovery and application development across cellular, molecular, and microscopic fields.
The company collaborates closely with customers in diagnostics, life science research, industrial research, biopharma applications, semiconductor metrology, and cleantech quality control.
BEST president and CEO Burkhard Prause said: “The expanded agreements demonstrate the confidence of major OEM customers in our capabilities in superconductor innovation, quality, and resilient supply chains, all required to keep them at the leading edge of technology and customer satisfaction.
“In particular, novel helium-free magnets are a new market driver, making MRI easier to site, more cost-effective and sustainable. Our latest superconductors address exacting requirements for stability and homogeneity, while enabling consistent, high-volume manufacturing.
“The expanded agreements continue important partnerships and ensure stability and growth in our superconductor business in the years to come.”
